11-09-2018
Pablo_K / iStockphoto.com
The US Court of Appeals for the Federal Circuit handed a win to the Broad Institute of Harvard and MIT yesterday, after finding that the research institute is entitled to some patents covering CRISPR technology.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Broad Institute, patent, CRISPR, PTAB, University of California, Berkeley, US Court of Appeals for the Federal Circuit, gene editing
Sigma-Aldrich submits CRISPR petition at USPTO
23-07-2019
USPTO revives fight over CRISPR patents
27-06-2019
LSIPR webinar: No end in sight for CRISPR IP saga, says HGF
13-03-2019
University of California to be granted CRISPR patent
11-02-2019
Broad Institute takes three lines of attack in CRISPR appeal filing
26-10-2017
PTAB says Broad's CRISPR patents do not interfere with UC Berkeley's
16-02-2017
